Abstract
Late I Na is an integral part of the sodium current, which persists long after the fast-inactivating component. The magnitude of the late I Na is relatively small in all species and in all types of cardiomyocytes as compared with the amplitude of the fast sodium current, but it contributes significantly to the shape and duration of the action potential. This late component had been shown to increase in several acquired or congenital conditions, including hypoxia, oxidative stress, and heart failure, or due to mutations in SCN5A, which encodes the α-subunit of the sodium channel, as well as in channel-interacting proteins, including multiple β subunits and anchoring proteins. Patients with enhanced late I Na exhibit the type-3 long QT syndrome (LQT3) characterized by high propensity for the life-threatening ventricular arrhythmias, such as Torsade de Pointes (TdP), as well as for atrial fibrillation. There are several distinct mechanisms of arrhythmogenesis due to abnormal late I Na, including abnormal automaticity, early and delayed afterdepolarization-induced triggered activity, and dramatic increase of ventricular dispersion of repolarization. Many local anesthetic and antiarrhythmic agents have a higher potency to block late I Na as compared with fast I Na. Several novel compounds, including ranolazine, GS-458967, and F15845, appear to be the most selective inhibitors of cardiac late I Na reported to date. Selective inhibition of late I Na is expected to be an effective strategy for correcting these acquired and congenital channelopathies.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrahamsson C, Carlsson L, Duker G (1996) Lidocaine and nisoldipine attenuate almokalant-induced dispersion of repolarization and early afterdepolarizations in vitro. J Cardiovasc Electrophysiol 7:1074–1081
Abriel H (2010) Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol 48:2–11
Ackerman MJ, Mohler PJ (2010) Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins. Circ Res 107:457–465
Ahern GP, Hsu SF, Klyachko VA, Jackson MB (2000) Induction of persistent sodium current by exogenous and endogenous nitric oxide. J Biol Chem 275:28810–28815
Ahern CA, Zhang JF, Wookalis MJ, Horn R (2005) Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res 96:991–998
Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM (2005) Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 97:1314–1322
Aiba T, Hesketh GG, Liu T, Carlisle R, Villa-Abrille MC, O’Rourke B, Akar FG, Tomaselli GF (2010) Na+ channel regulation by Ca2+/calmodulin and Ca2+/calmodulin-dependent protein kinase II in guinea-pig ventricular myocytes. Cardiovasc Res 85:454–463
Amin AS, Tan HL, Wilde AAM (2010) Cardiac ion channels in health and disease. Heart Rhythm 7:117–135
Anderson ME, Braun AP, Wu Y, Lu T, Wu Y, Schulman H, Sung RJ (1998) KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther 287:996–1006
Anderson ME, Brown JH, Bers DM (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51:468–473
Antzelevitch C (2007) Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm 4:964–972
Antzelevitch C (2008) Drug-induced spatial dispersion of repolarization. Cardiol J 15:100–121
Antzelevitch C, Belardinelli L (2006) The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis. J Cardiovasc Electrophysiol 17(Suppl 1):S79–S85
Antzelevitch C, Oliva A (2006) Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med 259:48–58
Antzelevitch C, Sicouri S (2012) Mechanisms underlying arrhythmogenesis in long QT syndrome. Card Electrophysiol Clin 4:17–27
Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, Di Diego JM, Saffitz J, Thomas GP (1999) The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10:1124–1152
Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas GP (2004) Electrophysiologic effects of ranolazine: a novel anti-anginal agent with antiarrhythmic properties. Circulation 110:904–910
Antzelevitch C, Guerchicoff A, Pollevick GD (2006) The role of spatial dispersion of repolarization in sudden cardiac death. ISHNE World Wide Internet Symposium on Sudden Cardiac Death, http://hf2010.ishne.org/vs/scd-2006/lectures/ing_antzelevitch_charles.pdf
Antzelevitch C, Burashnikov A, Sicouri S, Belardinelli L (2011) Electrophysiological basis for the antiarrhythmic actions of ranolazine. Heart Rhythm 8:1281–1290
Auerbach DS, Grzda KR, Furspan PB, Sato PY, Mironov S, Jalife J (2011) Structural heterogeneity promotes triggered activity, reflection and arrhythmogenesis in cardiomyocyte monolayers. J Physiol 589:2363–2381
Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS, Olson EN (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 106:2342–2347
Barajas-Martinez H, Hu D, Goodrow RJ Jr, Joyce F, Antzelevitch C (2013) Electrophysiologic characteristics and pharmacologic response of human cardiomyocytes isolated from a patient with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 36:1512–1515
Barnett ME, Madgwick DK, Takemoto DJ (2007) Protein kinase C as a stress sensor. Cell Signal 19:1820–1829
Baruscotti M, DiFrancesco D, Robinson RB (2000) Na(+) current contribution to the diastolic depolarization in newborn rabbit SA node cells. Am J Physiol Heart Circ Physiol 279:H2303–H2309
Bean BP, Cohen CJ, Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613–642
Belardinelli L, Antzelevitch C, Fraser H (2004) Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function. Eur Heart J Suppl 6:i3–i7
Belardinelli L, Shryock JC, Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92(Suppl 4):iv6–iv14
Belardinelli L, Liu G, Smith-Maxwell C, Wang WQ, El-Bizri N, Hirakawa R, Karpinski S, Kornyeyev D, Li CH, Hu L, Li XJ, Crumb W, Wu L, Koltun D, Zablocki J, Yao L, Dhalla AK, Rajamani S, Shryock J (2013) A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J Pharmacol Exp Ther 344:23–32
Ben CE, Boutjdir M, Himel HD, El-Sherif N (2008) Role of subendocardial Purkinje network in triggering torsade de pointes arrhythmia in experimental long QT syndrome. Europace 10:1218–1223
Benito B, Brugada R, Perich RM, Lizotte E, Cinca J, Mont L, Berruezo A, Tolosana JM, Freixa X, Brugada P, Brugada J (2008) A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Heart Rhythm 5:1434–1440
Bennett PB, Yazawa K, Makita N, George AL Jr (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature 376:683–685
Benoist D, Stones R, Drinkhill MJ, Benson AP, Yang Z, Cassan C, Gilbert SH, Saint DA, Cazorla O, Steele DS, Bernus O, White E (2012) Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension. Am J Physiol Heart Circ Physiol 302:H2381–H2395
Blaufox AD, Tristani-Firouzi M, Seslar S, Sanatani S, Trivedi B, Fischbach P, Paul T, Young ML, Tisma-Dupanovic S, Silva J, Cuneo B, Fournier A, Singh H, Tanel RE, Etheridge SP (2012) Congenital long QT 3 in the pediatric population. Am J Cardiol 109:1459–1465
Boutjdir M, El-Sherif N (1991) Pharmacological evaluation of early afterdepolarisations induced by sea anemone toxin (ATXII) in dog heart. Cardiovasc Res 25:815–819
Bryant SM, Wan X, Shipsey SJ, Hart G (1998) Regional differences in the delayed rectifier current (IKr and IKs) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc Res 40:322–331
Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116:1449–1457
Burnes JE, Ghanem RN, Waldo AL, Rudy Y (2001) Imaging dispersion of myocardial repolarization, I: comparison of body- surface and epicardial measures. Circulation 104:1299–1305
Capogrossi MC, Houser SR, Bahinski A, Lakatta EG (1987) Synchronous occurrence of spontaneous localized calcium release from the sarcoplasmic reticulum generates action potentials in rat cardiac ventricular myocytes at normal resting membrane potential. Circ Res 61:498–503
Carmeliet E (1987a) Slow inactivation of the sodium current in rabbit cardiac Purkinje fibers. Pflugers Arch 408:18–26
Carmeliet E (1987b) Voltage-dependent block by tetrodotoxin of the sodium channel in rabbit cardiac Purkinje fibers. Biophys J 51:109–114
Carter AJ, Grauert M, Pschorn U, Bechtel WD, Bartmann-Lindholm C, Qu Y, Scheuer T, Catterall WA, Weiser T (2000) Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL. Proc Natl Acad Sci U S A 97:4944–4949
Chaitman BR (2006) Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113:2462–2472
Chandler NJ, Greener ID, Tellez JO, Inada S, Musa H, Molenaar P, DiFrancesco D, Baruscotti M, Longhi R, Anderson RH, Billeter R, Sharma V, Sigg DC, Boyett MR, Dobrzynski H (2009) Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker. Circulation 119:1562–1575
Chandra R, Starmer CF, Grant AO (1998) Multiple effects of KPQ deletion mutation on gating of human cardiac Na+ channels expressed in mammalian cells. Am J Physiol 274:H1643–H1654
Chen YJ, Chen SA, Chang MS, Lin CI (2000) Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res 48:265–273
Cheung DW (1981) Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea-pig. J Physiol 314:445–456
Clancy CE, Rudy Y (1999) Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 400:566–569
Clancy CE, Tateyama M, Kass RS (2002) Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. J Clin Invest 110:1251–1262
Colatsky TJ (1982) Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers: an effect on steady-state sodium current? Circ Res 50:17–27
Coppini R, Ferrantini C, Yao L, Fan P, Del LM, Stillitano F, Sartiani L, Tosi B, Suffredini S, Tesi C, Yacoub M, Olivotto I, Belardinelli L, Poggesi C, Cerbai E, Mugelli A (2013) Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 127:575–584
Coraboeuf E, Deroubaix E, Coulombe A (1979) Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol 236:H561–H567
Curran J, Brown KH, Santiago DJ, Pogwizd S, Bers DM, Shannon TR (2010) Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II. J Mol Cell Cardiol 49:25–32
Damiano BP, Stump GL, Yagel SK (1991) Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity. J Cardiovasc Pharmacol 18:415–428
Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, George AL Jr, Roden DM (2008) Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117:1927–1935
Denac H, Mevissen M, Scholtysik G (2000) Structure, function and pharmacology of voltage-gated sodium channels. Naunyn Schmiedebergs Arch Pharmacol 362:453–479
Di Diego JM, Antzelevitch C (1993) Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 88:1177–1189
Eddlestone GT, Zygmunt AC, Antzelevitch C, Eddlestone GT, Zygmunt AC, Antzelevitch C (1996) Larger late sodium current contributes to the longer action potential of the M cell in canine ventricular myocardium. Pacing Clin Electrophysiol 19(Pt 2):569, Abstract
Edrich T, Wang SY, Wang GK (2005) State-dependent block of human cardiac hNav1.5 sodium channels by propafenone. J Membr Biol 207:35–43
Eigel BN, Gursahani H, Hadley RW (2004) ROS are required for rapid reactivation of Na+/Ca2+ exchanger in hypoxic reoxygenated guinea pig ventricular myocytes. Am J Physiol Heart Circ Physiol 286:H955–H963
Erickson JR, He BJ, Grumbach IM, Anderson ME (2011) CaMKII in the cardiovascular system: sensing redox states. Physiol Rev 91:889–915
Escande D, Coraboeuf E, Planche C, Lacour-Gayet F (1986) Effects of potassium conductance inhibitors on spontaneous diastolic depolarization and abnormal automaticity in human atrial fibers. Basic Res Cardiol 81:244–257
Fedida D (2007) Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent. Expert Opin Investig Drugs 16:519–532
Fedida D, Noble D, Rankin AC, Spindler AJ (1987) The arrhythmogenic transient inward current Iti and related contraction in isolated guinea-pig ventricular myocytes. J Physiol (London) 392:523–542
Fedida D, Orth PM, Hesketh JC, Ezrin AM (2006) The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers. J Cardiovasc Electrophysiol 17(Suppl 1):S71–S78
Ferrier GR, Saunders JH, Mendez C (1973) A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin. Circ Res 32:600–609
Fish JM, Antzelevitch C (2008) Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 19:301–308
Fraser H, Belardinelli L, Wang L, Light PE, McVeigh JJ, Clanachan AS (2006) Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J Mol Cell Cardiol 41:1031–1038
Fujiwara K, Tanaka H, Mani H, Nakagami T, Takamatsu T (2008) Burst emergence of intracellular Ca2+ waves evokes arrhythmogenic oscillatory depolarization via the Na+-Ca2+ exchanger: simultaneous confocal recording of membrane potential and intracellular Ca2+ in the heart. Circ Res 103:509–518
Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P, Boveda S, Doazan JP, Fauvel JM, Bounhoure JP (1998) QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J 19:1054–1062
Gautier M, Zhang H, Fearon IM (2008) Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J Mol Cell Cardiol 44:241–251
Gavillet B, Rougier JS, Domenighetti AA, Behar R, Boixel C, Ruchat P, Lehr HA, Pedrazzini T, Abriel H (2006) Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res 99:407–414
Gelband H, Bush HL, Rosen MR, Myerburg RJ, Hoffman BF (1972) Electrophysiologic properties of isolated preparations of human atrial myocardium. Circ Res 30:293–300
Ghanem RN, Burnes JE, Waldo AL, Rudy Y (2001) Imaging dispersion of myocardial repolarization, II: noninvasive reconstruction of epicardial measures. Circulation 104:1306–1312
Glass A, Sicouri S, Antzelevitch C (2007) Development of a coronary-perfused interventricular septal preparation as a model for studying the role of the septum in arrhythmogenesis. J Electrocardiol 40:S142–S144
Grant AO, Trantham JL, Brown KK, Strauss HC (1982) pH-dependent effects of quinidine on the kinetics of dV/dtmax in guinea pig ventricular myocardium. Circ Res 50:210–217
Grant AO, Dietz MA, Gilliam FR III, Starmer CF (1989) Blockade of cardiac sodium channels by lidocaine. Single-channel analysis. Circ Res 65:1247–1262
Grauert M, Bechtel WD, Weiser T, Stransky W, Nar H, Carter AJ (2002) Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke. J Med Chem 45:3755–3764
Guo T, Zhang T, Mestril R, Bers DM (2006) Ca2+/calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ Res 99:398–406
Guo D, Young LH, Wu Y, Belardinelli L, Kowey PR, Yan GX (2010) Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol 298:H1375–H1381
Haigney MC, Lakatta EG, Stern MD, Silverman HS (1994) Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90:391–399
Hammarstrom AK, Gage PW (2002) Hypoxia and persistent sodium current. Eur Biophys J 31:323–330
Harris DR, Green WL, Craelius W (1991) Acute thyroid hormone promotes slow inactivation of sodium current in neonatal cardiac myocytes. Biochim Biophys Acta 1095:175–181
Hartmann HA, Tiedeman AA, Chen S-F, Brown AM, Kirsch GE (1994) Effects of III-IV linker mutations on human heart Na+ channel inactivation gating. Circ Res 75:114–122
Heath BM, Cui Y, Worton S, Lawton B, Ward G, Ballini E, Doe CP, Ellis C, Patel BA, McMahon NC (2011) Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical. J Pharmacol Toxicol Methods 63:258–268
Hoch B, Meyer R, Hetzer R, Krause EG, Karczewski P (1999) Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 84:713–721
Hoeker GS, Katra RP, Wilson LD, Plummer BN, Laurita KR (2009) Spontaneous calcium release in tissue from the failing canine heart. Am J Physiol Heart Circ Physiol 297:H1235–H1242
Hogan PM, Davis LD (1968) Evidence for specialized fibers in the canine right atrium. Circ Res 23:387–396
Honerjager P (1982) Cardioactive substances that prolong the open state of sodium channels. Rev Physiol Biochem Pharmacol 92:1–74
Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez FE, Aris A, Cinca J (2004) Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 110:1358–1363
Hoyer K, Song Y, Wang D, Phan D, Balser J, Ingwall JS, Belardinelli L, Shryock JC (2011) Reducing the late sodium current improves cardiac fuction during sodium pump inhibition by ouabain. J Pharmacol Exp Ther 337:513–523
Hund TJ, Koval OM, Li J, Wright PJ, Qian L, Snyder JS, Gudmundsson H, Kline CF, Davidson NP, Cardona N, Rasband MN, Anderson ME, Mohler PJ (2010) A beta(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 120:3508–3519
Inomata N, Ishihara T (1988) Mechanism of inhibition by SUN 1165, a new Na channel blocking antiarrhythmic agent, of cardiac glycoside-induced triggered activity. Eur J Pharmacol 145:313–322
Isenberg G, Ravens U (1984) The effects of the anemonia sulcata toxin (ATX II) on membrane currents of isolated mammalian myocytes. J Physiol 357:127–149
Ji Y, Li B, Reed TD, Lorenz JN, Kaetzel MA, Dedman JR (2003) Targeted inhibition of Ca2+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17. J Biol Chem 278:25063–25071
Jia S, Lian J, Guo D, Xue X, Patel C, Yang L, Yuan Z, Ma A, Yan GX (2011) Modulation of the late sodium current by the toxin, ATX-II, and ranolazine affects the reverse use-dependence and proarrhythmic liability of I(Kr) blockade. Br J Pharmacol 164:308–316
John GW, Letienne R, Le GB, Pignier C, Vacher B, Patoiseau JF, Colpaert FC, Coulombe A (2004) KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties. Cardiovasc Drug Rev 22:17–26
Josephson IR, Sperelakis N (1989) Tetrodotoxin differentially blocks peak and steady-state sodium channel currents in early embryonic chick ventricular myocytes. Pflugers Arch 414:354–359
Ju YK, Saint DA, Gage PW (1996) Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 497(Pt 2):337–347
Kass RS, Lederer WJ, Tsien RW et al (1978) Role of calcium ions in transient inward currents and aftercontractions induced by strophantidin in cardiac Purkinje fibers. J Physiol (London) 281:187–208
Keung ECH, Aronson RS (1981) Transmembrane action potentials and the electrocardiogram in rats with renal hypertension. Cardiovasc Res 15:611–614
Kirchhefer U, Schmitz W, Scholz H, Neumann J (1999) Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res 42:254–261
Kiyosue T, Arita M (1989) Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ Res 64:389–397
Kohlhardt M, Fichtner H, Frobe U (1989) Metabolites of the glycolytic pathway modulate the activity of single cardiac Na+ channels. FASEB J 3:1963–1967
Kort AA, Lakatta EG, Marban E, Stern MD, Wier WG (1985) Fluctuations in intracellular calcium concentration and their effect on tonic tension in canine cardiac Purkinje fibres. J Physiol (London) 367:291–308
Le Grand B, Talmant JM, Rieu JP, Patoiseau JF, Colpaert FC, John GW (1995) Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential. J Cardiovasc Pharmacol 26:803–809
Li Z, Ai T, Samani K, Xi Y, Tzeng HP, Xie M, Wu S, Ge S, Taylor MD, Dong JW, Cheng J, Ackerman MJ, Kimura A, Sinagra G, Brunelli L, Faulkner G, Vatta M (2010) A ZASP missense mutation, S196L, leads to cytoskeletal and electrical abnormalities in a mouse model of cardiomyopathy. Circ Arrhythm Electrophysiol 3:646–656
Lipkind GM, Fozzard HA (2005) Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 68:1611–1622
Liu Y, DeFelice LJ, Mazzanti M (1992) Na channels that remain open throughout the cardiac action potential plateau. Biophys J 63:654–662
Liu H, Atkins J, Kass RS (2003) Common molecular determinants of flecainide and lidocaine block of heart Na + channels: evidence from experiments with neutral and quaternary flecainide analogues. J Gen Physiol 121:199–214
Liu X, Williams JB, Sumpter BR, Bevensee MO (2007) Inhibition of the Na/bicarbonate cotransporter NBCe1-A by diBAC oxonol dyes relative to niflumic acid and a stilbene. J Membr Biol 215:195–204
Lopez-Santiago LF, Meadows LS, Ernst SJ, Chen C, Malhotra JD, McEwen DP, Speelman A, Noebels JL, Maier SK, Lopatin AN, Isom LL (2007) Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J Mol Cell Cardiol 43:636–647
Lu HR, De CF (1993) R 56 865, a Na+/Ca(2+)-overload inhibitor, protects against aconitine-induced cardiac arrhythmias in vivo. J Cardiovasc Pharmacol 22:120–125
Ma J, Luo A, Wu L, Wan W, Zhang P, Ren Z, Zhang S, Qian C, Shryock JC, Belardinelli L (2012) Calmodulin kinase II and protein kinase C mediate the effect of increased intracellular calcium to augment late sodium current in rabbit ventricular myocytes. Am J Physiol Cell Physiol 302:C1141–C1151
Maier LS (2009) A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late INa using ranolazine. J Cardiovasc Pharmacol 54:279–286
Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM (2003) Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 92:904–911
Maier SK, Westenbroek RE, McCormick KA, Curtis R, Scheuer T, Catterall WA (2004) Distinct subcellular localization of different sodium channel a and b subunits in single ventricular myocytes from mouse heart. Circulation 109:1421–1427
Makielski JC, Farley AL (2006) Na(+) current in human ventricle: implications for sodium loading and homeostasis. J Cardiovasc Electrophysiol 17(Suppl 1):S15–S20
Makita N, Horie M, Nakamura T, Ai T, Sasaki K, Yokoi H, Sakurai M, Sakuma I, Otani H, Sawa H, Kitabatake A (2002) Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 106:1269–1274
Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, Schulze-Bahr E, Fukuhara S, Mochizuki N, Makiyama T, Itoh H, Christiansen M, McKeown P, Miyamoto K, Kamakura S, Tsutsui H, Schwartz PJ, George AL Jr, Roden DM (2008) The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 118:2219–2229
Maltsev VA, Undrovinas AI (2006) A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res 69:116–127
Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M, Undrovinas AI (1998) Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98:2545–2552
Maltsev VA, Sabbah HN, Undrovinas AI (2001) Late sodium current is a novel target for amiodarone: studies in failing human myocardium. J Mol Cell Cardiol 33:923–932
Maltsev VA, Silverman N, Sabbah HN, Undrovinas AI (2007) Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 9:219–227
Maltsev VA, Reznikov V, Undrovinas NA, Sabbah HN, Undrovinas A (2008) Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Am J Physiol Heart Circ Physiol 294:H1597–H1608
Maltsev VA, Kyle JW, Undrovinas A (2009) Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its b1 subunit. J Physiol Sci 59:217–225
Marban E, Robinson SW, Wier WG (1986) Mechanism of arrhythmogenic delayed and early afterdepolarizations in ferret muscle. J Clin Invest 78:1185–1192
Mary-Rabine L, Hordof AJ, Danilo P, Malm JR, Rosen MR (1980) Mechanisms for impulse initiation in isolated human atrial fibers. Circ Res 47:267–277
Mazzone A, Strege PR, Tester DJ, Bernard CE, Faulkner G, Degiorgio R, Makielski JC, Stanghellini V, Gibbons SJ, Ackerman MJ, Farrugia G (2008) A mutation in telethonin alters Nav1.5 function. J Biol Chem 283:16537–16544
McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L (2004) SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia1. Circulation 110:2163–2167
Meadows LS, Isom LL (2005) Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res 67:448–458
Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B, Valdivia C, Ueda K, Canizales-Quinteros S, Tusie-Luna MT, Makielski JC, Ackerman MJ (2007) SCN4B-encoded sodium channel b4 subunit in congenital long-QT syndrome. Circulation 116:134–142
Mike A, Lukacs P (2010) The enigmatic drug binding site for sodium channel inhibitors. Curr Mol Pharmacol 3:129–144
Milberg P, Reinsch N, Wasmer K, Monnig G, Stypmann J, Osada N, Breithardt G, Haverkamp W, Eckardt L (2005) Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3. Cardiovasc Res 65:397–404
Mines GR (1914) On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. Trans R Soc Can 8:43–52
Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, Timothy K, Priori SG, Keating MT, Bennett V (2004) A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 10:9137–9142
Moreno JD, Clancy CE (2012) Pathophysiology of the cardiac late Na current and its potential as a drug target. J Mol Cell Cardiol 52:608–619
Morrow DA (2007) MERLIN-TIMI-36 (Metabolic Efficiency with Ranolazine for Less Ischemia in NSTE ACS). Clin Cardiol 30:418–419
Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL (2008) Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 19:1289–1293
Murray KT, Hu NN, Daw JR, Shin HG, Watson MT, Mashburn AB, George AL Jr (1997) Functional effects of protein kinase C activation on the human cardiac Na+ channel. Circ Res 80:370–376
Narahashi T (2008) Tetrodotoxin: a brief history. Proc Jpn Acad Ser B Phys Biol Sci 84:147–154
Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K, Seipelt R, Schondube FA, Hasenfuss G, Maier LS (2010) CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 106:1134–1144
Nesterenko VV, Zygmunt AC, Rajamani S, Belardinelli L, Antzelevitch C (2011) Mechanisms of atrial-selective block of Na + channels by ranolazine: II. Insights from a mathematical model. Am J Physiol Heart Circ Physiol 301:H1615–H1624
Noble D, Noble PJ (2006) Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92(Suppl 4):iv1–iv5
Nof E, Burashnikov A, Antzelevitch C (2010) Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy. Heart Rhythm 7:251–257
Orth PM, Hesketh JC, Mak CK, Yang Y, Lin S, Beatch GN, Ezrin AM, Fedida D (2006) RSD1235 blocks late I(Na) and suppresses early afterdepolarizations and torsades de pointes induced by class III agents. Cardiovasc Res 70:486–496
Patel C, Antzelevitch C (2008a) Pharmacological approach to the treatment of long and short QT syndromes. Pharmacol Ther 118:138–151
Patel C, Antzelevitch C (2008b) Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. Heart Rhythm 5:585–590
Patlak JB, Ortiz M (1985) Slow currents through single sodium channels of the adult rat heart. J Gen Physiol 86:89–104
Petitprez S, Zmoos AF, Ogrodnik J, Balse E, Raad N, El-Haou S, Albesa M, Bittihn P, Luther S, Lehnart SE, Hatem SN, Coulombe A, Abriel H (2011) SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ Res 108:294–304
Pignier C, Rougier JS, Vie B, Culie C, Verscheure Y, Vacher B, Abriel H, Le GB (2010) Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias. Br J Pharmacol 161:79–91
Pinet C, Algalarrondo V, Sablayrolles S, Le GB, Pignier C, Cussac D, Perez M, Hatem SN, Coulombe A (2008) Protease-activated receptor-1 mediates thrombin-induced persistent sodium current in human cardiomyocytes. Mol Pharmacol 73:1622–1631
Remme CA, Verkerk AO, Nuyens D, Van Ginneken AC, Belterman CN, Wilders R, van Roon MA, Tan HL, Wilde AA, Carmeliet P, de Bakker JM, Veldkamp MW, Bezzina CR (2006) Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114:2584–2594
Restivo M, Caref EB, Kozhevnikov DO, El-Sherif N (2004) Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 15:323–331
Rivolta I, Abriel H, Tateyama M, Liu H, Memmi M, Vardas P, Napolitano C, Priori SG, Kass RS (2001) Inherited Brugada and LQT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem 276:30623–30630
Rodriguez P, Bhogal MS, Colyer J (2003) Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. J Biol Chem 278:38593–38600
Rook MB, Evers MM, Vos MA, Bierhuizen MF (2012) Biology of cardiac sodium channel Nav1.5 expression. Cardiovasc Res 93:12–23
Rosen MR, Danilo P Jr (1980) Effects of tetrodotoxin, lidocaine, verapamil and AHR-266 on ouabain induced delayed afterdepolarizations in canine Purkinje fibers. Circ Res 46:117–124
Rota M, Vassalle M (2003) Patch-clamp analysis in canine cardiac Purkinje cells of a novel sodium component in the pacemaker range. J Physiol 548:147–165
Ruan Y, Liu N, Priori SG (2009) Sodium channel mutations and arrhythmias. Nat Rev Cardiol 6:337–348
Sag CM, Wadsack DP, Khabbazzadeh S, Abesser M, Grefe C, Neumann K, Opiela MK, Backs J, Olson EN, Brown JH, Neef S, Maier SK, Maier LS (2009) Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ Heart Fail 2:664–675
Saint DA (2006) The role of the persistent Na(+) current during cardiac ischemia and hypoxia. J Cardiovasc Electrophysiol 17(Suppl 1):S96–S103
Saint DA (2008) The cardiac persistent sodium current: an appealing therapeutic target? Br J Pharmacol 153:1133–1142
Saint DA, Ju YK, Gage PW (1992) A persistent sodium current in rat ventricular myocytes. J Physiol (London) 453:219–231
Sakmann B, Spindler AJ, Bryant SM, Linz KW, Noble D (2000) Distribution of a persistent sodium current across the ventricular wall in guinea-pigs. Circ Res 87:910–914
Sarhan MF, Van PF, Ahern CA (2009) A double tyrosine motif in the cardiac sodium channel domain III-IV linker couples calcium-dependent calmodulin binding to inactivation gating. J Biol Chem 284:33265–33274
Sawanobori T, Hirano Y, Hiraoka M (1987) Aconitine-induced delayed afterdepolarization in frog atrium and guinea pig papillary muscles in the presence of low concentrations of Ca2+. Jpn J Physiol 37:59–79
Scherer D, von Lowenstern K, Zitron E, Scholz EP, Bloehs R, Kathofer S, Thomas D, Bauer A, Katus HA, Karle CA, Kiesecker C (2008) Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. Naunyn Schmiedebergs Arch Pharmacol 378:73–83
Scherf D, Romano FJ, Terranova R (1948) Experimental studies on auricular flutter and auricular fibrillation. Am Heart J 36:241–251
Schlotthauer K, Bers DM (2000) Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ Res 87:774–780
Schreibmayer W, Lindner W (1992) Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel. J Cardiovasc Pharmacol 20:324–331
Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FW, Gersh BJ, McCabe CH, Braunwald E (2007) Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the metabolic efficiency with ranolazine for less ischemia in non ST-elevation ACUTE CORONARY syndrome thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116:1647–1652
Shao D, Okuse K, Djamgoz MB (2009) Protein-protein interactions involving voltage-gated sodium channels: post-translational regulation, intracellular trafficking and functional expression. Int J Biochem Cell Biol 41:1471–1481
Shattock MJ, Bers DM (1989) Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol 256:C813–C822
Sheu SS, Lederer WJ (1985) Lidocaine’s negative inotropic and antiarrhythmic actions: dependence on shortening of action potential duration and reduction of intracellular sodium activity. Circ Res 57:578–590
Shimizu W, Antzelevitch C (1997a) Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 as well as LQT3 models of the long QT syndrome. Pacing Clin Electrophysiol 20:1234, Abstract
Shimizu W, Antzelevitch C (1997b) Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 96:2038–2047
Shimizu W, Antzelevitch C (1998) Cellular basis for the ECG features of the LQT1 form of the long QT syndrome: effects of b-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98:2314–2322
Shimizu W, Antzelevitch C (1999a) Spontaneous and stimulation-induced Torsade de Pointes in LQT1, LQT2 and LQT3 models of the long QT syndrome. Circulation 100(II):359, Abstract
Shimizu W, Antzelevitch C (1999b) Cellular basis for long QT, transmural dispersion of repolarization, and Torsade de Pointes in the long QT syndrome. J Electrocardiol 32(Suppl):177–184
Shryock JC, Song Y, Rajamani S, Antzelevitch C, Belardinelli L (2013) The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res 99:600–611
Sicouri S, Fish J, Antzelevitch C (1994) Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 5:824–837
Sicouri S, Quist M, Antzelevitch C (1996) Evidence for the presence of M cells in the guinea pig ventricle. J Cardiovasc Electrophysiol 7:503–511
Sicouri S, Antzelevitch D, Heilmann C, Antzelevitch C (1997a) Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long QT syndrome. J Cardiovasc Electrophysiol 8:1280–1290
Sicouri S, Moro S, Litovsky SH, Elizari MV, Antzelevitch C (1997b) Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 8:1269–1279
Sicouri S, Glass A, Ferreiro M, Antzelevitch C (2010) Transseptal dispersion of repolarization and its role in the development of torsade de pointes arrhythmias. J Cardiovasc Electrophysiol 21:441–447
Sicouri S, Blazek J, Belardinelli L, Antzelevitch C (2012a) Electrophysiological characteristics of canine superior vena cava sleeve preparations. Effect of ranolazine. Circ Arrhythm Electrophysiol 5:371–379
Sicouri S, Pourrier M, Gibson JK, Lynch JJ, Antzelevitch C (2012b) Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations. Heart Rhythm 9:422–429
Sicouri S, Blazek J, Belardinelli L, Antzelevitch C (2012c) Antiarrhythmic effects of the highly-selective late sodium channel current blocker GS 458967 in canine Purkinje fibers and pulmonary vein sleeve preparations. Heart Rhythm 9:S186, Abstract
Sicouri S, Belardinelli L, Antzelevitch C (2013) Antiarrhythmic effects of the highly-selective late sodium channel current blocker GS-458967. Heart Rhythm 10(7):1036–1043
Sidorov VY, Uzelac I, Wikswo JP (2011) Regional increase of extracellular potassium leads to electrical instability and reentry occurrence through the spatial heterogeneity of APD restitution. Am J Physiol Heart Circ Physiol 301:H209–H220
Song JH, Huang CS, Nagata K, Yeh JZ, Narahashi T (1997) Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 282:707–714
Song Y, Shryock JC, Wu L, Belardinelli L (2004) Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 44:192–199
Song Y, Shryock J, Wagner S, Maier LS, Belardinelli L (2006) Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318:214–222
Song Y, Shryock JC, Belardinelli L (2008) An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am J Physiol Heart Circ Physiol 294:H2031–H2039
Song Y, Shryock JC, Belardinelli L (2009) A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes. Am J Physiol Heart Circ Physiol 297:H1254–H1262
Sossalla S, Wagner S, Rasenack EC, Ruff H, Weber SL, Schondube FA, Tirilomis T, Tenderich G, Hasenfuss G, Belardinelli L, Maier LS (2008) Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts–role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 45:32–43
Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schondube FA, Hasenfuss G, Belardinelli L, Maier LS (2010) Altered Na+ currents in atrial fibrillation: effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 55:2330–2342
Sossalla S, Maurer U, Schotola H, Hartmann N, Didie M, Zimmermann WH, Jacobshagen C, Wagner S, Maier LS (2011) Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIdelta(C) can be reversed by inhibition of late Na(+) current. Basic Res Cardiol 106:263–272
Spencer CI, Sham JS (2005) Mechanisms underlying the effects of the pyrethroid, tefluthrin, on action potential duration in isolated rat ventricular myocytes 1. J Pharmacol Exp Ther 315:16–23
Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT (2002) Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297:1333–1336
Starmer CF, Nesterenko VV, Undrovinas AI, Grant AO, Rosenshtraukh LV (1991) Lidocaine blockade of continuously and transiently accessible sites in cardiac sodium channels. J Mol Cell Cardiol 23(Suppl I):73–83
Stern MD, Capogrossi MC, Lakatta EG (1988) Spontaneous calcium release from the sarcoplasmic reticulum in myocardial cells: mechanisms and consequences. Cell Calcium 9:247–256
Sunami A, Fan Z, Sawanobori T, Hiraoka M (1993) Use-dependent block of Na + currents by mexiletine at the single channel level in guinea-pig ventricular myocytes. Br J Pharmacol 110:183–192
Tamareille S, Le GB, John GW, Feuvray D, Coulombe A (2002) Anti-ischemic compound KC 12291 prevents diastolic contracture in isolated atria by blockade of voltage-gated sodium channels. J Cardiovasc Pharmacol 40:346–355
Tan BH, Pundi KN, Van Norstrand DW, Valdivia CR, Tester DJ, Medeiros-Domingo A, Makielski JC, Ackerman MJ (2010) Sudden infant death syndrome–associated mutations in the sodium channel beta subunits. Heart Rhythm 7:771–778
Tang L, Joung B, Ogawa M, Chen PS, Lin SF (2012) Intracellular calcium dynamics, shortened action potential duration, and late-phase 3 early after depolarization in langendorff-perfused rabbit ventricles. J Cardiovasc Electrophysiol 23:1364–1371
Trautwein W, Kassebaum DG, Nelson RM, HECHTHH (1962) Electrophysiological study of human heart muscle. Circ Res 10:306–312
Tsuchida K, Otomo S (1990) Electrophysiological effects of Monensin, a sodium ionophore, on cardiac Purkinje fibers. Eur J Pharm 190:313–320
Tweedie D, Harding SE, MacLeod KT (2000) Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes. J Mol Cell Cardiol 32:261–272
Ueda N, Zipes DP, Wu J (2004) Prior ischemia enhances arrhythmogenicity in isolated canine ventricular wedge model of long QT 3. Cardiovasc Res 63:69–76
Ueda K, Valdivia C, Medeiros-Domingo A, Tester DJ, Vatta M, Farrugia G, Ackerman MJ, Makielski JC (2008) Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci U S A 105:9355–9360
Undrovinas A, Maltsev VA (2008a) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6:348–359
Undrovinas A, Maltsev VA (2008b) Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6:348–359
Undrovinas AI, Fleidervish IA, Makielski JC (1992) Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 71:1231–1241
Undrovinas AI, Maltsev VA, Sabbah HN (1999) Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 55:494–505
Undrovinas AI, Maltsev VA, Kyle JW, Silverman N, Sabbah HN (2002) Gating of the late Na+ channel in normal and failing human myocardium. J Mol Cell Cardiol 34:1477–1489
Undrovinas AI, Undrovinas NA, Belardinelli L, Sabbah HN (2004) Ranolazine inhibits late sodium current in isolated left ventricular myocytes of dogs with heart failure. J Am Coll Cardiol 43(supplA):178A, Abstract
Undrovinas AI, Belardinelli L, Undrovinas NA, Sabbah HN (2006) Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17:S161–S177
Undrovinas NA, Maltsev VA, Belardinelli L, Sabbah HN, Undrovinas A (2010) Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure. J Physiol Sci 60:245–257
Vacher B, Pignier C, Letienne R, Verscheure Y, Le GB (2009) F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models. Br J Pharmacol 156:214–225
Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, Makielski JC (2005) Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 38:475–483
Vatta M, Faulkner G (2006) Cytoskeletal basis of ion channel function in cardiac muscle. Future Cardiol 2:467–476
Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA (2006) Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114:2104–2112
Verdonck F, Bielen FV, Ver DL (1991) Preferential block of the veratridine-induced, non-inactivating Na + current by R56865 in single cardiac Purkinje cells. Eur J Pharmacol 203:371–378
Vermeulen JT, Tan HL, Rademaker H, Schumacher CA, Loh P, Opthof T, Coronel R, Janse MJ (1996) Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium. J Mol Cell Cardiol 28:123–131
Vollmer B, Meuter C, Janssen PA (1987) R 56865 prevents electrical and mechanical signs of ouabain intoxication in guinea-pig papillary muscle. Eur J Pharmacol 142:137–140
Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, Maier SK, Zhang T, Hasenfuss G, Brown JH, Bers DM, Maier LS (2006) Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest 116:3127–3138
Wagner S, Ruff HM, Weber SL, Bellmann S, Sowa T, Schulte T, Anderson ME, Grandi E, Bers DM, Backs J, Belardinelli L, Maier LS (2011) Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res 108:555–565
Wang Q, Shen J, Li Z, Timothy KW, Vincent GM, Priori SG, Schwartz PJ, Keating MT (1995) Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 4:1603–1607
Wang DW, Yazawa K, George AL Jr, Bennett PB (1996) Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A 93:13200–13205
Wang DW, Crotti L, Shimizu W, Pedrazzini M, Ikeda T, Schwartz PJ, George AL (2008) Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ Arrhythm Electrophysiol 1:370–378
Wang DW, Mistry AM, Kahlig KM, Kearney JA, Xiang J, George AL Jr (2010) Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Front Pharmacol 1:144
Ward CA, Giles WR (1997) Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 500(Pt 3):631–642
Ward CA, Bazzazi H, Clark RB, Nygren A, Giles WR (2006) Actions of emigrated neutrophils on Na(+) and K(+) currents in rat ventricular myocytes. Prog Biophys Mol Biol 90:249–269
Weiss S, Benoist D, White E, Teng W, Saint DA (2010) Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current. Br J Pharmacol 160:1072–1082
West JW, Patton DE, Scheuer T (1992) A cluster of hydrophobic amino acid residues required for fast Na+ channel inactivation. Proc Natl Acad Sci U S A 89:10910–10914
Wilhelm D, Himmel H, Ravens U, Peters T (1991) Characterization of the interaction of R 56865 with cardiac Na- and L-type Ca channels. Br J Pharmacol 104:483–489
Wilson LD, Jeyaraj D, Wan X, Hoeker GS, Said TH, Gittinger M, Laurita KR, Rosenbaum DS (2009) Heart failure enhances susceptibility to arrhythmogenic cardiac alternans. Heart Rhythm 6:251–259
Wit AL, Cranefield PF (1977) Triggered and automatic activity in the canine coronary sinus. Circ Res 41:435–445
Wit AL, Rosen MR (1983) Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J 106:798–811
Witchel HJ, Dempsey CE, Sessions RB, Perry M, Milnes JT, Hancox JC, Mitcheson JS (2004) The low-potency, voltage-dependent HERG blocker propafenone–molecular determinants and drug trapping. Mol Pharmacol 66:1201–1212
Wu J, Corr PB (1995) Palmitoylcarnitine increases [Na+]i and initiates transient inward current in adult ventricular myocytes. Am J Physiol 268:H2405–H2417
Wu L, Song Y, Shryock JC, Li Y, Antzelevitch C, Belardinelli L (2003) Ranolazine attenuates the prolongation of ventricular monophasic action potential and suppresses ventricular tachycardia caused by sea anemone toxin, ATX-II, in guinea pig isolated hearts. PACE 26:1023, Abstract
Wu L, Shryock JC, Song Y, Li Y, Antzelevitch C, Belardinelli L (2004) Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome. J Pharmacol Exp Ther 310:599–605
Wu L, Shryock JC, Song Y, Belardinelli L (2006) An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 316:718–726
Wu G, Ai T, Kim JJ, Mohapatra B, Xi Y, Li Z, Abbasi S, Purevjav E, Samani K, Ackerman MJ, Qi M, Moss AJ, Shimizu W, Towbin JA, Cheng J, Vatta M (2008a) a-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circ Arrhythm Electrophysiol 1:193–201
Wu L, Guo D, Li H, Hackett J, Yan GX, Jiao Z, Antzelevitch C, Shryock JC, Belardinelli L (2008b) Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. Heart Rhythm 5:1726–1734
Wu L, Rajamani S, Shryock JC, Li H, Ruskin J, Antzelevitch C, Belardinelli L (2008c) Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. Cardiovasc Res 77:481–488
Wu Y, Song Y, Belardinelli L, Shryock JC (2009a) The late Na+ current (INa) inhibitor ranolazine attenuates effects of Palmitoyl-L-Carnitine to increase late INa and cause ventricular diastolic dysfunction. J Pharmacol Exp Ther 330:550–557
Wu L, Rajamani S, Li H, January CT, Shryock JC, Belardinelli L (2009b) Reduction of repolarization researve unmasks the pro-arrhythmic role of endogenous late sodium current in the heart. Am J Physiol Heart Circ Physiol 297:H1048–H1057
Wu L, Ma J, Li H, Wang C, Grandi E, Zhang P, Luo A, Bers DM, Shryock JC, Belardinelli L (2011) Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization. Circulation 123:1713–1720
Xiao XH, Allen DG (1999) Role of Na(+)/H(+) exchanger during ischemia and preconditioning in the isolated rat heart. Circ Res 85:723–730
Xie LH, Chen F, Karagueuzian HS, Weiss JN (2009) Oxidative-stress-induced after depolarizations and calmodulin kinase II signaling. Circ Res 104:79–86
Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR (2001) Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-qt syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103:2851–2856
Yao L, Fan P, Jiang Z, Viatchenko-Karpinski S, Wu Y, Kornyeyev D, Hirakawa R, Budas GR, Rajamani S, Shryock JC, Belardinelli L (2011) Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol 301:C577–C586
Yatani A, Akaike N (1985) Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. J Mol Cell Cardiol 17:467–476
Zaza A, Belardinelli L, Shryock JC (2008) Pathophysiology and pharmacology of the cardiac “late sodium current”. Pharmacol Ther 119:326–339
Zeiler RH, Gough WB, El-Sherif N (1984) Electrophysiologic effects of propafenone on canine ischemic cardiac cells. Am J Cardiol 54:424–429
Zellerhoff S, Pistulli R, Monnig G, Hinterseer M, Beckmann BM, Kobe J, Steinbeck G, Kaab S, Haverkamp W, Fabritz L, Gradaus R, Breithardt G, Schulze-Bahr E, Bocker D, Kirchhof P (2009) Atrial arrhythmias in long-QT syndrome under daily life conditions: a nested case control study. J Cardiovasc Electrophysiol 20:401–407
Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N, Chang S, Ling H, Bers DM, Maier LS, Olson EN, Brown JH (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282:35078–35087
Zhang XQ, Yamada S, Barry WH (2008) Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia. J Cardiovasc Pharmacol 51:443–449
Zhang T, Yong SL, Drinko JK, Popovic ZB, Shryock JC, Belardinelli L, Wang QK (2011) LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol 147:239–245
Zhao G, Walsh E, Shryock JC, Messina E, Wu Y, Zeng D, Xu X, Ochoa M, Baker SP, Hintze TH, Belardinelli L (2011) Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs. J Cardiovasc Pharmacol 57:639–647
Zicha S, Maltsev VA, Nattel S, Sabbah HN, Undrovinas AI (2004) Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure1. J Mol Cell Cardiol 37:91–100
Zimmer T, Surber R (2008) SCN5A channelopathies - an update on mutations and mechanisms. Prog Biophys Mol Biol 98:120–136
Zygmunt AC, Eddlestone GT, Thomas GP, Nesterenko VV, Antzelevitch C (2001) Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol 281:H689–H697
Zygmunt AC, Nesterenko VV, Rajamani S, Hu D, Barajas-Martinez H, Belardinelli L, Antzelevitch C (2011) Mechanisms of atrial-selective block of sodium channel by ranolazine I. Experimental analysis of the use-dependent block. Am J Physiol Heart Circ Physiol 301:H1606–H1614
Support
Supported by grants HL47678 from NHLBI, NIH (CA), C026424 from NYSTEM (CA), Gilead Sciences, Inc. and the Masons of New York State, Florida, Massachusetts Connecticut, Maryland, Rhode Island, and Wisconsin.
Conflicts of Interest
Dr. Antzelevitch is a consultant to Gilead Sciences and Dr. Belardinelli, Shryock, and Rajamani are employed by Gilead Sciences.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Antzelevitch, C., Nesterenko, V., Shryock, J.C., Rajamani, S., Song, Y., Belardinelli, L. (2014). The Role of Late I Na in Development of Cardiac Arrhythmias. In: Ruben, P. (eds) Voltage Gated Sodium Channels. Handbook of Experimental Pharmacology, vol 221. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41588-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-41588-3_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41587-6
Online ISBN: 978-3-642-41588-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)